Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Pathogen cell wall" is broad and non-specific, commonly referring to the carbohydrate- and protein-rich extracellular matrix surrounding cells of pathogenic bacteria, fungi, and some other microorganisms. In bacteria, the cell wall is primarily composed of peptidoglycan, which gives structural strength and determines shape; in Gram-positive types, the wall is thick and includes teichoic acids, while in Gram-negative bacteria, it is thinner and overlaid by an outer membrane containing lipopolysaccharide[1][3][6]. In fungi, the cell wall consists mainly of chitin and glucans, with various mannoproteins and, in some species, an additional polysaccharide capsule[2][6]. In plants, the cell wall is made of cellulose, hemicellulose, and pectin[4][5], but this is not typically considered a "pathogen cell wall." The cell wall serves as a critical therapeutic target because it is essential for microbial viability and absent in animal cells, allowing for selective toxicity. Numerous antibiotics and antifungal agents disrupt biosynthesis or integrity of the cell wall, resulting in pathogen death or growth inhibition. However, the term "Pathogen cell wall" is not a specific molecular entity—rather, it refers to a structural feature common to many, but not all, pathogens. Within drug discovery and therapeutics, actual targets are typically specific biosynthetic enzymes or assembly proteins (e.g., penicillin-binding proteins, beta-(1,3)-glucan synthase) rather than the cell wall structure as a whole. Note: - is_incorrect: true — The term “Pathogen cell wall” does not refer to a unique molecular target but rather a class of structures with diverse composition across various organisms. Proper targets would be specific cell wall biosynthetic enzymes or structural proteins in specific pathogens. - canonical_abbreviation: null — There is no standard abbreviation, as this is not a single molecular entity. - aliases include several generic or organism-specific names, as context varies.
Inhibition of peptidoglycan synthesis (bacteria); inhibition of beta-glucan/chitin synthesis (fungi); disruption of cell wall cross-linking; increased cell wall permeability leading to cell lysis (sometimes by enzymatic degradation).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen cell wall.